MedTrace Logo

Acute Tocolysis With Terbutaline for Suspected Fetal Distress

NCT05326269 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-04-13

No results posted yet for this study

Summary

The trial was to determine the effect of administrating subcutaneous terbutaline prior to emergency caesarean delivery for suspected fetal distress

Conditions

  • Nonreassuring Fetal Status

Interventions

DRUG

Terbutaline

Subcutaneous injection

Sponsors & Collaborators

  • Hospital Kemaman

    lead OTHER

Principal Investigators

  • Zahar A Zakaria, MD · Hospital Kemaman

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-23
Primary Completion
2019-09-15
Completion
2019-09-15

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05326269 on ClinicalTrials.gov